Anna Forsyth

1.1k total citations · 1 hit paper
27 papers, 502 citations indexed

About

Anna Forsyth is a scholar working on Cognitive Neuroscience, Clinical Psychology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anna Forsyth has authored 27 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cognitive Neuroscience, 11 papers in Clinical Psychology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anna Forsyth's work include Functional Brain Connectivity Studies (12 papers), Psychedelics and Drug Studies (11 papers) and Advanced MRI Techniques and Applications (7 papers). Anna Forsyth is often cited by papers focused on Functional Brain Connectivity Studies (12 papers), Psychedelics and Drug Studies (11 papers) and Advanced MRI Techniques and Applications (7 papers). Anna Forsyth collaborates with scholars based in New Zealand, United States and Switzerland. Anna Forsyth's co-authors include Suresh Muthukumaraswamy, Thomas Lumley, Rachael L. Sumner, Rebecca McMillan, Gemma Malpas, Doug Campbell, Juergen Dukart, Elizabeth A. Maxwell, Joerg F. Hipp and Rhys Ponton and has published in prestigious journals such as Nature Communications, Biological Psychiatry and Psychopharmacology.

In The Last Decade

Anna Forsyth

25 papers receiving 498 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blinding and expectancy confounds in psychedelic randomized controlled trials

2021 187 citations Suresh Muthukumaraswamy, Anna Forsyth et al. Expert Review of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Forsyth New Zealand	12	288	174	141	127	98	27	502
Robin von Rotz Switzerland	10	282 1.0×	204 1.2×	184 1.3×	63 0.5×	41 0.4×	17	427
Bruno Roméo France	14	256 0.9×	147 0.8×	134 1.0×	70 0.6×	159 1.6×	40	653
Joseph P. Barsuglia United States	14	424 1.5×	215 1.2×	205 1.5×	73 0.6×	53 0.5×	18	570
F.X. Vollenweider Switzerland	9	443 1.5×	198 1.1×	353 2.5×	82 0.6×	72 0.7×	23	597
Collin Reiff United States	8	499 1.7×	240 1.4×	195 1.4×	60 0.5×	137 1.4×	11	653
Anna Neukirch Germany	6	215 0.7×	83 0.5×	219 1.6×	129 1.0×	69 0.7×	7	424
Federico Zamberlán Argentina	12	344 1.2×	136 0.8×	167 1.2×	130 1.0×	53 0.5×	16	491
Samuel Turton United Kingdom	10	227 0.8×	91 0.5×	166 1.2×	71 0.6×	21 0.2×	16	446
Josep María Fábregas Spain	5	457 1.6×	157 0.9×	217 1.5×	37 0.3×	117 1.2×	7	505
Sophia Armand Denmark	10	204 0.7×	115 0.7×	115 0.8×	49 0.4×	25 0.3×	21	331

Countries citing papers authored by Anna Forsyth

Since Specialization

Citations

This map shows the geographic impact of Anna Forsyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Forsyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Forsyth more than expected).

Fields of papers citing papers by Anna Forsyth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Forsyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Forsyth. The network helps show where Anna Forsyth may publish in the future.

Co-authorship network of co-authors of Anna Forsyth

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Forsyth. A scholar is included among the top collaborators of Anna Forsyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Forsyth. Anna Forsyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donegan, C, Rachael L. Sumner, Anna Forsyth, et al.. (2026). LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 145. 111645–111645. 1 indexed citations

Daldegan‐Bueno, Dimitri, C Donegan, Rachael L. Sumner, et al.. (2025). LSD microdosing in major depressive disorder: results from an open-label trial. Neuropharmacology. 283. 110762–110762. 1 indexed citations

Forsyth, Anna, et al.. (2025). Tū Wairua: Development of an Indigenous Rongoā Māori approach to healing with psilocybin containing mushrooms. ResearchSpace (University of Auckland). 9(4). 369–384. 1 indexed citations

Hipp, Joerg F., Anna Forsyth, Sofie L. Valk, et al.. (2025). Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changes. Nature Communications. 16(1). 8248–8248.

Donegan, C, Dimitri Daldegan‐Bueno, Tehseen Noorani, et al.. (2025). Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures. Neuropharmacology. 280. 110670–110670. 1 indexed citations

Muthukumaraswamy, Suresh, Matthew J. Baggott, Eduardo Ekman Schenberg, et al.. (2025). Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. Therapeutic Advances in Psychopharmacology. 15. 1967298386–1967298386.

Allen, Nathan, Rachael L. Sumner, Anna Forsyth, et al.. (2024). LSD increases sleep duration the night after microdosing. Translational Psychiatry. 14(1). 191–191. 7 indexed citations

Daldegan‐Bueno, Dimitri, C Donegan, Anna Forsyth, et al.. (2024). LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder. Trials. 25(1). 560–560. 9 indexed citations

Sumner, Rachael L., Rebecca McMillan, Anna Forsyth, Suresh Muthukumaraswamy, & Alexander D. Shaw. (2024). Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine. Translational Psychiatry. 14(1). 116–116. 1 indexed citations

10.

Gaebler, Arnim Johannes, Jana Zweerings, Juergen Dukart, et al.. (2023). Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI. Translational Psychiatry. 13(1). 59–59. 18 indexed citations

11.

Sumner, Rachael L., William J. Evans, Rhys Ponton, et al.. (2023). Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial. Biological Psychiatry. 94(6). 511–521. 37 indexed citations

12.

Donegan, C, Dimitri Daldegan‐Bueno, Rachael L. Sumner, et al.. (2023). An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1). Pilot and Feasibility Studies. 9(1). 169–169. 12 indexed citations

13.

Forsyth, Anna, Rebecca McMillan, Juergen Dukart, Joerg F. Hipp, & Suresh Muthukumaraswamy. (2021). Effects of Ketamine and Midazolam on Simultaneous EEG/fMRI Data During Working Memory Processes. Brain Topography. 34(6). 863–880. 6 indexed citations

14.

Muthukumaraswamy, Suresh, Anna Forsyth, & Thomas Lumley. (2021). Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Review of Clinical Pharmacology. 14(9). 1133–1152. 187 indexed citations breakdown →

15.

Henn, Dominic, et al.. (2021). High‐capacity multimodal anion‐exchange membranes for polishing of therapeutic proteins. Biotechnology Progress. 37(3). e3129–e3129. 11 indexed citations

16.

Irwin, Jessica L., John S. Warner, Michael Snow, et al.. (2020). Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health. PubMed. 18. 100077–100077. 3 indexed citations

17.

Forsyth, Anna, et al.. (2020). On the Quality, Statistical Efficiency, and Safety of Simultaneously Recorded Multiband fMRI/EEG. Brain Topography. 33(3). 303–316. 6 indexed citations

18.

McMillan, Rebecca, Rachael L. Sumner, Anna Forsyth, et al.. (2019). Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 99. 109838–109838. 43 indexed citations

19.

Forsyth, Anna, et al.. (2019). Children with autism spectrum disorder: Pilot studies examining the salivary microbiome and implications for gut metabolism and social behavior. 15. 100066–100066. 16 indexed citations

20.

Forsyth, Anna, Rebecca McMillan, Doug Campbell, et al.. (2018). Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedation. Psychopharmacology. 235(12). 3479–3493. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact